CTNNB1 and neoplasm: To validate the therapeutic efficacy of drugs predicted by ModCellTM, we next determined tumor cell viability upon drug treatment using a recently developed drug testing platform comprised of five liver tumor cell lines and seven established PDX lines, most of which show Wnt activation mainly through CTNNB1 or AXIN1 mutations (Supp.